No abstract available
Publication types
-
Clinical Trial, Phase II
-
Research Support, N.I.H., Extramural
MeSH terms
-
Dermatologic Agents* / therapeutic use
-
Humans
-
Interleukin 1 Receptor Antagonist Protein / adverse effects
-
Psoriasis* / drug therapy
-
Skin Diseases, Vesiculobullous* / drug therapy
Substances
-
Interleukin 1 Receptor Antagonist Protein
-
Dermatologic Agents